| scholarly article | Q13442814 |
| P356 | DOI | 10.3350/CMH.2015.21.4.365 |
| P8608 | Fatcat ID | release_p2gd3ap2rbhdbmgbohqib7737m |
| P932 | PMC publication ID | 4712164 |
| P698 | PubMed publication ID | 26770925 |
| P5875 | ResearchGate publication ID | 290453490 |
| P50 | author | Ayman Alsebaey | Q64910880 |
| Maha Mohamed Elsabaawy | Q88943109 | ||
| Eman Abdelsameea | Q89329713 | ||
| Eman Rewisha | Q130270974 | ||
| P2093 | author name string | Manar Abdelaal Obada | |
| Shimaa Rashad Abdelhamid | |||
| Tary Abdelhamid Salman | |||
| P2860 | cites work | Guidelines on the management of ascites in cirrhosis | Q24676541 |
| Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study | Q28344354 | ||
| Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club | Q33836637 | ||
| Liver cirrhosis | Q34010340 | ||
| Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites | Q34313920 | ||
| An evidence-based manual for abdominal paracentesis | Q36773699 | ||
| Ascites in cirrhosis: a review of management and complications. | Q36949605 | ||
| Review article: Management of ascites and associated complications in patients with cirrhosis | Q37032763 | ||
| Ascites: diagnosis and management | Q37540945 | ||
| EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis | Q37773059 | ||
| Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist | Q38245219 | ||
| Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes | Q39034682 | ||
| Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study. | Q39042814 | ||
| Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites | Q43003630 | ||
| Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites | Q43040656 | ||
| Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study | Q43556243 | ||
| Large-volume paracentesis and intravenous saline: effects on the renin-angiotensin system | Q44151244 | ||
| Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial | Q44870019 | ||
| Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction. | Q44935277 | ||
| Post-paracentesis circulatory derangements are related to monocyte activation | Q44992157 | ||
| Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study | Q46545710 | ||
| Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study | Q46646322 | ||
| The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites--a randomized multicentric study. | Q46771214 | ||
| Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities | Q46912629 | ||
| Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study | Q46929734 | ||
| Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study | Q56925266 | ||
| Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: | Q56925418 | ||
| Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis | Q61576654 | ||
| Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis | Q61576735 | ||
| Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites | Q73322900 | ||
| Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study | Q79765130 | ||
| Management of adult patients with ascites due to cirrhosis: an update | Q83932911 | ||
| Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study | Q84528260 | ||
| Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012 | Q86283845 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | liver cirrhosis | Q147778 |
| P304 | page(s) | 365-371 | |
| P577 | publication date | 2015-12-24 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction | |
| P478 | volume | 21 |
| Q92484973 | Current approaches to the management of patients with cirrhotic ascites |
| Q91795118 | Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review |
| Q39250455 | Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective. |
| Q43089477 | What we know about paracentesis induced circulatory dysfunction? |
Search more.